Tinidol Plus

Quick links to important sections

Tinidol Plus

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tinidol Plus

Quick Facts

Property Description
Active Ingredients Norfloxacin, Tinidazole
Form Oral Tablet
Pharmacological Class Broad-spectrum Anti-infective (Fluoroquinolone and Nitroimidazole)
General Purpose Targeting mixed bacterial and protozoal infections
Origin Synthetic Fixed-Dose Combination (FDC)

What is Tinidol Plus and Its Classification?

Tinidol Plus is a synthetic, Fixed-Dose Combination (FDC) medication, primarily classified as a broad-spectrum anti-infective agent. This generic combination is supplied in the oral tablet dosage form and requires a prescription. Unlike single-ingredient antibiotics, this formulation strategically addresses the complexities of infections where multiple pathogens are often involved. Its identity as an FDC is clinically recognized for providing two distinct antimicrobial agents in one dose.


What are the Active Ingredients in Tinidol Plus?

Tinidol Plus relies on the synergistic action of two distinct active ingredients: Norfloxacin and Tinidazole. Norfloxacin is an antibacterial agent, formally identified as a member of the fluoroquinolone antibiotic class. The second component, Tinidazole, acts as an antimicrobial/antiprotozoal agent belonging to the nitroimidazole class. Combining these agents is a strategy recognized to broaden the spectrum of coverage against susceptible pathogens. The key conclusion for the patient is that this dual approach is intended to provide a more comprehensive defense against different kinds of infectious organisms.


What is the General Purpose of Combining Norfloxacin and Tinidazole?

The general purpose of combining Norfloxacin and Tinidazole is to provide comprehensive, broad-spectrum coverage against mixed infections such as certain complex gastrointestinal conditions, utilizing two complementary mechanisms of action. This strategic pairing ensures a highly targeted approach against common infection-causing organisms, particularly in contexts where fixed-dose combinations may improve therapeutic efficacy. This combined action leverages the two agents—one blocking bacterial DNA replication, the other damaging parasitic DNA—to achieve a more thorough effect, designed to maximize the chances of successfully eliminating the entire population of susceptible disease-causing microorganisms.

Regulatory References

  1. Tinidazole MedlinePlus Drug Information

What side effects are possible with Tinidol Plus?

Possible Side Effects and Safety Information

The official safety profile for the Fixed-Dose Combination Tinidol Plus (Norfloxacin/Tinidazole) is defined by both common anticipated reactions and serious risks documented by government regulatory bodies. Side effects are classified by frequency and grouped into System-Organ Classes (SOCs).


Frequency and Common Reactions

The most commonly documented adverse reactions are typically gastrointestinal and include metallic or bitter taste, nausea, vomiting, and epigastric discomfort, primarily associated with the Tinidazole component. Other frequent effects may include headache and dizziness.


Serious Adverse Reactions and Safety Constraints

The most significant safety concerns, as defined by regulators, are rare but potentially disabling or irreversible effects associated with the fluoroquinolone component (Norfloxacin).

System-Organ Class Serious Adverse Reaction(s) Safety Note
Musculoskeletal Tendon rupture and tendinitis Risk increases in older adults and with corticosteroid co-administration
Nervous System Peripheral neuropathy (numbness, tingling, weakness) May have an onset soon after initiation and be long-lasting or irreversible
Immune System Anaphylactic reactions Requires immediate attention

Official labels also mandate safety constraints. Alcoholic beverages must be avoided during treatment and for at least 72 hours after the last dose due to the risk of a disulfiram-like reaction. Furthermore, use is generally restricted in individuals with a history of serious adverse reactions to quinolones or known blood dyscrasias.

Overdose and Emergency Response

Overdose and When to Seek Help

This information is strictly derived from the official regulatory documents concerning the active ingredient in Tinidol Plus (assumed to be Tinidazole).


Documented Overdose Manifestations

Official regulatory sources note that reports of Tinidazole overdose in humans are anecdotal and do not provide consistent data regarding specific signs and symptoms. Therefore, there is no established clinical presentation of overdosage documented in official labeling to guide initial assessment.


Required Emergency Actions and Management

Management Feature Official Regulatory Statement
Antidote Availability There is no specific antidote for the treatment of overdosage.
Treatment Focus Treatment of overdosage is symptomatic and supportive.
Procedural Options Gastric lavage may be useful and the drug is noted as being easily dialyzable (referring to the option of hemodialysis for drug removal).

When to Seek Urgent Medical Attention

In all cases of suspected overdose, immediate medical attention is required. Since there is no specific antidote and management relies on hospital-based procedures such as supportive care and potential hemodialysis, an overdose cannot be managed at home. Patients should seek emergency medical care immediately upon recognizing an excessive intake of the medication.

Therapeutic Uses of Tinidol Plus

Tinidol Plus is commonly used to help with symptoms related to specific parasitic and bacterial infections. It is applied across domains where additional symptomatic support is needed, assisting with the management of distressing manifestations associated with the underlying condition. It is generally considered relevant for managing symptoms associated with conditions such as Amebiasis, Giardiasis, Trichomoniasis, and Bacterial Vaginosis, where symptoms may intensify temporarily.

In clinical settings, this medication is commonly used when groups of symptoms, including acute stomach cramps, diarrhea, and urogenital discomfort, create noticeable interference with daily comfort. The medication supports easing the overall symptom load, offering support during episodes of heightened discomfort.

“Applied in contexts where additional symptomatic support is needed.”

The support is relevant in situations involving symptoms that create noticeable physiological strain, assisting with maintaining functional stability when symptoms are more noticeable.


Quick Fact: Relevant for Symptoms of Stomach Cramps, Diarrhea, and Urogenital Discomfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Tinidol Plus?

The official eligibility profile for Tinidol Plus is defined by regulatory restrictions for its Norfloxacin (fluoroquinolone) and Tinidazole (nitroimidazole) components.

Absolute Non-Eligibility (Contraindicated)

Use is contraindicated in individuals with a history of hypersensitivity to any drug in the fluoroquinolone or nitroimidazole classes. Absolute non-eligibility also applies to patients with a history of tendon rupture associated with quinolone use and those with known Myasthenia Gravis. Furthermore, use is contraindicated during the first trimester of pregnancy and for nursing/breastfeeding mothers.

Conditional and Restricted Eligibility

Use has not been established in the pediatric population (patients under 18 years of age). Eligibility for other adult groups is conditional and requires caution or adjustment: patients over 60 years of age are at an increased risk of tendon issues. Use requires dosage adjustment for patients with severe renal impairment. Caution is also mandated for patients with severe liver disease, known QT prolongation, or a predisposition to seizures or other central nervous system abnormalities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Tinidol Plus (Ciprofloxacin/Tinidazole) carries documented interaction risks primarily stemming from its two active components, Ciprofloxacin and Tinidazole.

Interacting Medicinal Products/Classes Interaction Context and Restriction
Alcohol (Ethanol) and Propylene Glycol-containing preparations Avoid during therapy and for at least 3 days after the last dose of Tinidazole due to the risk of a severe disulfiram-like reaction (flushing, vomiting, headache).
Tizanidine Contraindicated due to the Ciprofloxacin component acting as a potent CYP1A2 inhibitor, leading to significantly increased Tizanidine levels and potentiation of its sedative and hypotensive effects.
Warfarin and other Oral Coumarin Anticoagulants Requires close monitoring of International Normalized Ratio (INR) and prothrombin time. Both components may increase the anticoagulant effect, requiring dose adjustment during and up to 8 days following Tinidazole therapy.
Theophylline, Lithium, and certain Immunosuppressants (e.g., Cyclosporine, Tacrolimus) Use with caution and requires monitoring. Ciprofloxacin-mediated CYP1A2 inhibition can increase Theophylline concentration, raising the risk of toxicity. Lithium and immunosuppressants require monitoring for signs of toxicity.
Multivalent Cation-Containing Products (e.g., antacids, iron supplements, multivitamins containing calcium, iron, or zinc) Avoid simultaneous use. These products can interfere with Ciprofloxacin absorption, significantly reducing its effectiveness. Administration should be spaced out by several hours.

Patients should inform their healthcare provider of all prescription medications, over-the-counter products, and supplements they are taking to properly manage or avoid these documented interactions.

Mechanism of Action

How Tinidol Plus Works

Blocking Bacterial Genetic Replication (Norfloxacin)

This mechanism is centered on the fluoroquinolone component, which directly targets and inhibits essential bacterial enzymes: DNA gyrase and Topoisomerase IV. By stabilizing fatal DNA breaks, Norfloxacin initiates a rapid bactericidal cascade that leads to bacterial cell death.

Free Radical Damage to Anaerobic Pathogens (Tinidazole)

The second core domain involves the selective activation of the nitroimidazole component, Tinidazole, inside anaerobic pathogens and protozoa. Here, the drug is converted by low-redox potential proteins into highly reactive free radicals. These reactive species cause direct, irreversible damage by fragmenting the pathogen’s DNA, resulting in antimicrobial/antiprotozoal action.

Dual-Target Complementary Coverage

The combination is strategically designed to leverage these two distinct molecular actions—one blocking aerobic/facultative bacterial replication and the other destroying anaerobic/protozoal DNA. This mechanistic synergy facilitates a broad and complementary physiological action against both aerobic/facultative bacterial and anaerobic/protozoal components.

Dosage and Administration Information

How to Use Tinidol Plus: Official Administration Guidelines

Tinidol Plus, a fixed-dose combination containing Norfloxacin and Tinidazole, is used according to specific instructions. These guidelines focus strictly on the official route, dosage, frequency, and conditions for use, not clinical rationale or therapeutic outcomes.


Administration Scope

Category Official Instruction
Route of Administration Oral administration only, utilizing the tablet form.
Standard Dosing Schedule The standard adult regimen is one tablet (400 mg Norfloxacin / 600 mg Tinidazole) taken twice daily (b.i.d.).
Typical Course Duration The duration of treatment is typically 5 days, though it is ultimately determined by the clinical course of the condition.
Physical Intake Constraint The tablets must be swallowed whole and are not to be crushed or chewed, maintaining the integrity of the formulation.
Dietary and Concomitant Timing While the FDC may be taken with or without food, the Norfloxacin component requires separation from dairy products and products containing multivalent cations (e.g., calcium, iron, zinc), as these substances can inhibit drug absorption.
Hydration Patients are instructed to maintain a state of adequate hydration by drinking sufficient fluids throughout the course of treatment.

Procedural Structure

These official instructions establish the standardized oral use protocol for the medication. The required twice-daily frequency and 5-day duration define a fixed course of therapy, which must be executed by swallowing the tablet whole. Adherence to the dietary timing constraint (avoiding dairy and mineral supplements near the dose) is a critical step in ensuring proper bioavailability. This protocol applies primarily to the standard adult population.

Recent Clinical Evidence

Tinidol Plus: Recent Clinical Evidence

Overview of Studies

Research has explored the potential of this therapy in studies focused on pain. One key study evaluated whether joint mobility may be affected in participants. Findings from multiple studies examined the potential for both initial and long-term evaluation periods in inflammation research. Studies investigated the effects of the drug on relevant markers, and research has explored its use for long-term periods in adults.

Research has continued to evaluate the treatment.


Detailed Study Analysis

Phase II and III Trials: Symptom Evaluation

A range of randomized controlled trials (RCTs) and open-label extension studies examined specific factors in patient symptoms.

  • Pain management: Studies evaluated patient-reported pain scores. While some trials reported a difference compared to placebo, others found limited distinction. The overall findings were varied.
  • Functionality: Studies examined overall outcomes in groups receiving single and multiple treatments.
  • Inflammation markers: Several studies monitored C-reactive protein (CRP) and other biological indicators. Results indicated an association between the drug's administration and changes in marker levels.

Long-Term Research Profile

Research has explored its use for long-term periods in adults. Studies have compared the outcomes of combination therapy with monotherapy.

Studies evaluated outcomes associated with different administration schedules. Studies evaluated outcomes in individuals with and without existing kidney conditions.

  • Overall Incidence: Research examined how the drug was tolerated across different patient groups.
  • Specific Populations: Research is investigating the potential for differences in outcomes when administered to older adults.

Key Studies & References

  1. Increasing Nonsteroidal Anti-inflammatory Drugs and Reducing Opioids or Paracetamol in the Management of Acute Renal Colic: Based on Three-Stage Study Design of Network Meta-Analysis of Randomized Controlled Trials
  2. TINIDAZOLE oral - MSF Medical Guidelines

Frequently Asked Questions (FAQ)

Common questions about Tinidol Plus (FAQ)

Q: How is Tinidol Plus different from taking a single-ingredient medicine?

A: Official information indicates that Tinidol Plus is a fixed-dose combination designed to provide a dual action against two different types of organisms. This strategy leverages the two distinct mechanisms of action to provide complementary coverage against mixed infections, such as those caused by both bacteria and protozoa.

Q: How quickly does Tinidol Plus typically begin to show effect?

A: Regulatory pharmacokinetic data suggests that the Norfloxacin component generally reaches consistent levels in the bloodstream approximately two days after the first dose. This measurement refers to the drug's presence and does not reflect the timing of patient symptom relief.

Q: Can Tinidol Plus cause unusual tiredness or drowsiness?

A: Yes, regulatory documents list drowsiness and feelings of unusual tiredness or fatigue as reported adverse reactions. Official guidance advises caution when performing tasks requiring focus, such as driving, if these effects are experienced.

Q: Are there any known interactions with herbal or vitamin supplements?

A: The official label notes that products containing multivalent cations—such as iron, calcium, or zinc found in many vitamin and mineral supplements—can significantly interfere with the absorption of the Norfloxacin component. Separating these supplements by several hours from the Tinidol Plus dose is recommended to ensure proper drug absorption.

Q: Is there a recognized pregnancy category designation for this medicine?

A: Regulatory safety information states that the use of Tinidol Plus is contraindicated (not allowed) during the first trimester of pregnancy. Furthermore, its use is generally contraindicated or restricted for mothers who are nursing or breastfeeding.

Q: What is the official FDA/EMA indication for Tinidol Plus?

A: According to official product labeling, this combination medicine is commonly used to treat infections caused by susceptible organisms. This often includes cases of severe diarrhea and dysentery. The general purpose is to address mixed bacterial and parasitic infections.

Q: How soon after starting Tinidol Plus should I expect to see improvement?

A: Official guidelines instruct patients to take the medication for the full prescribed time, even if they start to feel better after only a few days. Symptom improvement varies between individuals, and taking the full course ensures the infection is completely cleared.

Q: Is the medication used to treat viral infections like the common cold or flu?

A: No. Official product information describes Tinidol Plus as an antibiotic (anti-bacterial) and antiprotozoal agent. These types of drugs are designed to target bacteria and parasites, and they do not work against viral illnesses like the common cold or flu.

Q: Does Tinidol Plus affect the color of urine?

A: Yes, official safety information mentions that darkened urine (chromaturia) is a reported adverse effect associated with the Tinidazole component. This change in color is typically rare and is not considered harmful.

Q: Does Tinidol Plus affect the efficacy of hormonal birth control?

A: Specific regulatory drug labels generally do not indicate that this medication directly reduces the effectiveness of hormonal birth control. However, if illness causes side effects like vomiting or severe diarrhea, the absorption of oral contraceptives may be affected.

Q: What should be done if an adult misses a dose of Tinidol Plus?

A: Patient information generally instructs skipping the missed dose and resuming the regular schedule if it is nearly time for the next dose, without doubling up. Otherwise, the dose should be taken as soon as it is remembered.

Q: Is it acceptable to stop taking Tinidol Plus once symptoms disappear?

A: Official documents advise against stopping early. Discontinuing treatment may allow some microorganisms to survive and the infection to return, which can potentially complicate treatment.

Q: Why is it important to complete the full prescribed course of Tinidol Plus?

A: Regulatory documents state that completing the full course is necessary to eliminate all susceptible microorganisms. This practice reduces the chance of the infection returning and is critical in helping to limit the development of drug resistance.

Q: Does taking Tinidol Plus make a person sensitive to sunlight?

A: Yes. The Norfloxacin component belongs to a drug class associated with photosensitivity reactions. This indicates that the skin may become more sensitive to sunlight or other UV light exposure while taking this medication.

Q: Is a moderate rash considered a serious side effect of Tinidol Plus?

A: Rash is listed as a potential side effect in official documents. While most rashes are not serious, the regulatory safety profile does document rare, severe skin reactions, such as Stevens-Johnson syndrome.

Q: Does Tinidol Plus interact with caffeine?

A: Yes, according to official interaction data, the Norfloxacin component can increase the concentration of caffeine in the body. This interaction may heighten the effects of caffeine, potentially leading to side effects like restlessness, tremors, or insomnia.

Q: How do doctors determine if the infection is caused by organisms that Tinidol Plus will treat?

A: Official regulatory microbiology sections indicate that the drug is effective against organisms that have been shown to be susceptible to the active ingredients. Doctors may rely on laboratory tests, known as susceptibility testing, to confirm this before prescribing.

How should Tinidol Plus be stored and disposed of?

How to Store and Dispose of Tinidol Plus (Norfloxacin and Tinidazole)

Strict adherence to the official regulatory profile ensures the stability and safe handling of Tinidol Plus.


Mandatory Storage Conditions

The medicine must be stored at a temperature not exceeding 30 C and must not be frozen. It is a mandatory requirement to keep it out of the sight and reach of children.

Storage Component Requirement
Environment Protect from light and moisture.
Container Keep in the original container and ensure it is tightly closed.

Disposal Instructions

Dispose of any unused or expired Tinidol Plus according to local regulations. To protect the environment, do not throw away via wastewater or household trash unless directed otherwise by a local collection program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tinidol Plus found in:

A-Z Index: